13-30464144-TAAAAA-TAAAAAAA

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The ENST00000399489.5(HMGB1):​c.-466_-465dupTT variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 0)
Exomes 𝑓: 0.0000016 ( 0 hom. )

Consequence

HMGB1
ENST00000399489.5 5_prime_UTR

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.403

Publications

0 publications found
Variant links:
Genes affected
HMGB1 (HGNC:4983): (high mobility group box 1) This gene encodes a protein that belongs to the High Mobility Group-box superfamily. The encoded non-histone, nuclear DNA-binding protein regulates transcription, and is involved in organization of DNA. This protein plays a role in several cellular processes, including inflammation, cell differentiation and tumor cell migration. Multiple pseudogenes of this gene have been identified. Alternative splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Sep 2015]
HMGB1 Gene-Disease associations (from GenCC):
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000399489.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HMGB1
NM_002128.7
MANE Select
c.-14-452_-14-451dupTT
intron
N/ANP_002119.1P09429
HMGB1
NM_001313892.2
c.-15+15_-15+16dupTT
intron
N/ANP_001300821.1P09429
HMGB1
NM_001313893.1
c.-14-452_-14-451dupTT
intron
N/ANP_001300822.1P09429

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HMGB1
ENST00000399489.5
TSL:1
c.-466_-465dupTT
5_prime_UTR
Exon 1 of 5ENSP00000382412.1Q5T7C4
HMGB1
ENST00000341423.10
TSL:1 MANE Select
c.-14-452_-14-451dupTT
intron
N/AENSP00000345347.5P09429
HMGB1
ENST00000468384.1
TSL:1
n.120-452_120-451dupTT
intron
N/A

Frequencies

GnomAD3 genomes
Cov.:
0
GnomAD4 exome
AF:
0.00000159
AC:
1
AN:
630148
Hom.:
0
Cov.:
0
AF XY:
0.00000342
AC XY:
1
AN XY:
292060
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000770
AC:
1
AN:
12984
American (AMR)
AF:
0.00
AC:
0
AN:
726
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3850
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2738
South Asian (SAS)
AF:
0.00
AC:
0
AN:
12576
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
232
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1248
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
575204
Other (OTH)
AF:
0.00
AC:
0
AN:
20590
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.325
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
0

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.40

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5802568; hg19: chr13-31038281; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.